Form 4 for ELV Elevance Health
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001156039-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +44.3K | 153.5K | +41% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $468.81 | -20.1K | 109.2K | -16% | -$9.42M |
| D | 2023-03-03 | 2023-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +32.4K | 32.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 8,422 | $0.00 | 117,602 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 2,807 shares each on 3/1/2024 and 3/1/2025 and 2,808 shares on 3/1/2026. |
| 2 | Common | Common Stock | 2023-03-02 | F | D | 17,614 | $468.78 | 135,863 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. (F4) Balance includes 236.42 shares acquired on December 21, 2022 through a dividend reinvestment plan. |
| 3 | Common | Common Stock | 2023-03-01 | A | A | 35,875 | $0.00 | 153,477 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/2/2023. |
| 4 | Common | Common Stock | 2023-03-01 | F | D | 2,471 | $469.03 | 109,180 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-03-01 | A | A | 32,380 | $0.00 | 32,380 | D | $469.03 · — to 2033-03-01 | 32,380 Common Stock | (F5) The option represents a right to purchase a total of 32,380 shares, and is exercisable in two installments of 10,793 shares each and one installment of 10,794 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. |